What's in Il-Yang Pharm. Co., Ltd.'s pipeline?

Il-Yang Pharm. Co., Ltd. has 19 drugs in our index: 1 marketed, 0 filed, 7 in Phase 3, 0 in Phase 2, 11 in Phase 1.

Which companies overlap with Il-Yang Pharm. Co., Ltd.'s portfolio?

Top competitors by shared drug class: Sinovac Biotech Co., Ltd, GlaxoSmithKline, Sanofi Pasteur, a Sanofi Company, Centers for Disease Control and Prevention, Seqirus.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/il-yang-pharm-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Il-Yang Pharm. Co., Ltd. — Portfolio Competitive Intelligence Brief

Il-Yang Pharm. Co., Ltd. pipeline: 1 marketed, 0 filed, 7 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 7 Phase 3 0 Phase 2 11 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Ilaprazole + Amoxicillin	Ilaprazole + Amoxicillin	marketed	Proton pump inhibitor + Beta-lactam antibiotic combination	H+/K+-ATPase (ilaprazole); Bacterial cell wall peptidoglycan (amoxicillin)	Gastroenterology
IL-YANG Flu Vaccine Pre-filled Syringe	IL-YANG Flu Vaccine Pre-filled Syringe	phase 3	inactivated influenza vaccine		Immunology
IL-YANG Quadrivalent Influenza Vaccine	IL-YANG Quadrivalent Influenza Vaccine	phase 3	Inactivated quadrivalent influenza vaccine		Immunology / Infectious Disease
IL-YANG Flu Vaccine Prefilled Syringe	IL-YANG Flu Vaccine Prefilled Syringe	phase 3	Inactivated influenza vaccine		Immunology
Radotinib HCl	Radotinib HCl	phase 3	BCR-ABL tyrosine kinase inhibitor	BCR-ABL	Oncology
IL-YANG Trivalent Influenza Vaccine	IL-YANG Trivalent Influenza Vaccine	phase 3	Inactivated influenza vaccine		Immunology
Fluarix Tetra Pre-filled Syringe	Fluarix Tetra Pre-filled Syringe	phase 3	Inactivated influenza vaccine (quadrivalent)	Influenza virus surface antigens (hemagglutinin and neuraminidase)	Immunology / Infectious Disease
VAXIGRIP Prefilled Syringe INJ.	VAXIGRIP Prefilled Syringe INJ.	phase 3	vaccine		Infectious Disease

Therapeutic area mix

Immunology · 3
Immunology / Infectious Disease · 2
Gastroenterology · 1
Infectious Disease · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sinovac Biotech Co., Ltd · 4 shared drug classes
GlaxoSmithKline · 4 shared drug classes
Sanofi Pasteur, a Sanofi Company · 3 shared drug classes
Centers for Disease Control and Prevention · 3 shared drug classes
Seqirus · 3 shared drug classes
National Institute of Allergy and Infectious Diseases (NIAID) · 2 shared drug classes
Insight Therapeutics, LLC · 2 shared drug classes
Novartis · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Il-Yang Pharm. Co., Ltd.:

Cite this brief

Drug Landscape (2026). Il-Yang Pharm. Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/il-yang-pharm-co-ltd. Accessed 2026-05-14.